Latigo Biotherapeutics, Inc. Common Stock (LTGO)

Date: O: H: L: C: Vol:

Finanzdaten der Latigo Biotherapeutics, Inc. Common Stock-Aktie (LTGO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30
Periodenlänge	3 Monate
	25.81
Research and Development	21.23
Operating Income/Loss	-25.81
Nonoperating Income/Loss	0.01
Income Tax Expense/Benefit	-
	-25.80
Attributable To Parent	-25.80
Available To Common Stockholders, Basic	-25.80
Basic Average Shares	0.94
Diluted Average Shares	0.94
Basic Earnings Per Share	-27.59
Diluted Earnings Per Share	-27.59